Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Pharmstandard International: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Pharmstandard International
Pharmstandard International
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Dec 5, 2017
Neon Therapeutics
$36.0M Series B Extension
—
Access Industries
,
ArrowMark Partners
,
Casdin Capital
, Fidelity Management & Research Company
,
Hillhouse Capital Group
, Nextech Invest
, Partner Fund Management
,
Wellington Management
Aug 1, 2016
Avelas Biosciences
$20.0M Series C
Andrei Petrov
Avalon Ventures
,
Alexandria Venture Investments
,
Bregua Corporation
,
Ervington Investments
,
WuXi Healthcare Ventures
Dec 1, 2015
Allena Pharmaceuticals
$53.0M Series C
Partner Fund Management
Frazier Healthcare Partners
, Markus Goebel
, Fidelity Management & Research Company
, HBM Partners
,
Wellington Management
Jul 1, 2015
Protagonist Therapeutics
$40.0M Series C
Canaan Partners
Adage Capital Management
,
Foresite Capital
, Johnson & Johnson Innovation
,
Lilly Ventures
, RA Capital Management
,
Starfish Ventures
Apr 23, 2015
Jounce Therapeutics, Inc.
$56.0M Series B
—
Casdin Capital
,
Cormorant Asset Management
,
Foresite Capital
, Nextech Invest
,
Omega Funds
, Michael Lee
,
Wellington Management
Dec 1, 2014
Allena Pharmaceuticals
$25.0M Series B
HBM Partners
Atlas Venture
,
Bessemer Venture Partners
,
Frazier Healthcare Partners
,
Third Rock Ventures
,
Ysios Capital
, Markus Goebel
May 16, 2014
Proteon Therapeutics
$45.0M Series D
Tim Haines
Bessemer Venture Partners
,
Deerfield Management
,
Devon Park Bioventures
,
Intersouth Partners
,
MPM Capital
, Dmitry Kobyzev, Ph.D.
,
Prism VentureWorks
,
Skyline Ventures
,
TVM Capital
,
Vectis Healthcare and Life Sciences Fund
Nov 20, 2013
Argos Therapeutics
$17.5M Series E Extension
—
Aurora Funds
,
Forbion
,
Green Cross Holdings
,
Intersouth Partners
,
Lumira Ventures
,
Morningside
,
TVM Capital
Sep 19, 2013
Protagonist Therapeutics
$4.0M Series B Extension
Pharmstandard International
—
Aug 28, 2013
Argos Therapeutics
$42.5M Series E
Alexandr Shuster
Aurora Funds
,
Forbion
,
Green Cross Holdings
,
Intersouth Partners
,
Lumira Ventures
,
Morningside
,
TVM Capital